Opportunity Information: Apply for RFA AT 24 002

The funding opportunity "Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)" (RFA-AT-24-002) is a National Institutes of Health (NIH) cooperative agreement intended to continue support for a single Coordinating Center that provides national leadership for the NIH-DoD-VA Pain Management Collaboratory (PMC). The PMC focuses on advancing evidence-based, non-pharmacological approaches to pain management for U.S. veterans, active-duty military personnel, and/or their family members, with an emphasis on carrying out research in real-world health care delivery settings connected to the Department of Veterans Affairs (VA) and the Department of Defense (DoD). As a U24 cooperative agreement, the award is structured for substantial NIH involvement in the program, and it is explicitly designated as "Clinical Trial Not Allowed," meaning the Coordinating Center itself is not proposing or running an independent clinical trial as its primary activity.

At its core, the Coordinating Center is meant to function as the operational and scientific backbone of the broader collaboratory. The NOFO lays out three major responsibilities. First, the Coordinating Center must develop, adapt, and promote technical and policy guidance and best practices that make it easier to conduct high-quality research in partnership with health care systems serving veterans and military communities. This includes practical guidance on common barriers in embedded or pragmatic research, such as working within clinical workflows, handling multi-site operational differences, aligning research procedures with health system policies, and addressing issues that come up when research is tightly integrated into routine care. Second, the Coordinating Center must collaborate directly with the PMC Demonstration Project teams by providing hands-on support across study design and implementation. This support is geared toward helping demonstration teams develop and execute pragmatic trial protocols within participating health care settings, including assistance with methodological planning, operational troubleshooting, and harmonizing approaches across projects when appropriate. Third, the Coordinating Center is responsible for broad dissemination of the collaboratory's endorsed policies, best practices, and lessons learned from the demonstration projects so that methods and tools developed through PMC can be used by other researchers and health systems interested in implementing non-pharmacological pain management research in routine care environments.

Beyond the technical and scientific support functions, the Coordinating Center also serves as the central administrative and coordination hub for the PMC program. A key part of that role is supporting the PMC Steering Committee and its subcommittees, which typically involves organizing meetings, maintaining documentation, facilitating cross-project communication, and ensuring consistent processes for decision-making and collaborative work. In other words, the Coordinating Center is expected to keep the collaboratory functioning as a cohesive national program rather than a collection of unrelated projects, while also strengthening the infrastructure and shared playbook for doing embedded pain management research across NIH-DoD-VA contexts.

Eligibility is broad across many U.S.-based organization types, including state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses); and small businesses, among others. The NOFO also highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and U.S. territories or possessions. However, the opportunity is restricted to domestic applicants: non-U.S. entities (foreign organizations and foreign institutions) cannot apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed.

Key administrative details included in the source information are that this is a discretionary funding opportunity under a cooperative agreement mechanism, in the health and education activity category, associated with CFDA numbers 93.213, 93.273, and 93.361. The listed award ceiling is $1,300,000, and the original application closing date was August 31, 2023 (with the record created June 28, 2023). Overall, the opportunity is designed to sustain a centralized coordinating infrastructure that improves how pragmatic, health-system-partnered research on non-drug pain management is designed, implemented, and shared across NIH, DoD, and VA settings, ultimately supporting scalable improvements in pain care for service members, veterans, and their families.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.273, 93.361.
  • This funding opportunity was created on 2023-06-28.
  • Applicants must submit their applications by 2023-08-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,300,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AT 24 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-AT-24-002)

What is this funding opportunity?

This opportunity is a National Institutes of Health (NIH) cooperative agreement to continue support for a single Coordinating Center for the NIH-DoD-VA Pain Management Collaboratory (PMC). The Coordinating Center is intended to provide national leadership and serve as the operational and scientific backbone of the collaboratory.

What is the program mechanism and what does it imply?

The mechanism is a U24 cooperative agreement. A cooperative agreement indicates substantial NIH involvement in the program, meaning NIH is expected to participate actively in the oversight and direction of the funded activities compared with a standard grant.

Is a clinical trial allowed under this award?

No. The opportunity is explicitly designated as "U24 Clinical Trial Not Allowed," which means the Coordinating Center itself is not proposing or running an independent clinical trial as its primary activity.

What is the Pain Management Collaboratory (PMC) focused on?

PMC focuses on advancing evidence-based, non-pharmacological approaches to pain management for U.S. veterans, active-duty military personnel, and/or their family members. It emphasizes carrying out research in real-world health care delivery settings connected to the Department of Veterans Affairs (VA) and the Department of Defense (DoD).

What are the Coordinating Center's main responsibilities?

The Coordinating Center has three major responsibilities described in the opportunity:

  • Develop, adapt, and promote technical and policy guidance and best practices to make it easier to conduct high-quality research in partnership with VA- and DoD-connected health care systems.
  • Collaborate directly with PMC Demonstration Project teams by providing hands-on support across study design and implementation (including methodological planning, operational troubleshooting, and harmonizing approaches across projects when appropriate).
  • Disseminate endorsed policies, best practices, and lessons learned from the demonstration projects so PMC methods and tools can be used by other researchers and health systems.

What kinds of barriers or practical issues is the Coordinating Center expected to address?

The opportunity highlights common barriers in embedded or pragmatic research, including working within clinical workflows, handling multi-site operational differences, aligning research procedures with health system policies, and addressing issues that arise when research is integrated into routine care.

How does the Coordinating Center support PMC Demonstration Projects?

The Coordinating Center provides hands-on support to demonstration teams to help them develop and execute pragmatic trial protocols within participating health care settings. This includes help with study design, implementation planning, troubleshooting operational challenges, and aligning or harmonizing approaches across projects when appropriate.

What does "real-world health care delivery settings" mean in this context?

In this opportunity, it refers to research conducted in routine care environments connected to VA and DoD systems, where studies must fit within existing clinical workflows and operational realities rather than being run solely as tightly controlled research settings.

What is meant by "non-pharmacological approaches to pain management"?

The collaboratory is centered on non-drug approaches to pain management. The provided information does not list specific interventions, but it clearly distinguishes the focus as non-pharmacological (non-medication) strategies.

What is the Coordinating Center's role in dissemination?

The Coordinating Center is responsible for broad dissemination of the collaboratory's endorsed policies, best practices, and lessons learned so that tools and methods developed through PMC can be adopted by other researchers and health systems interested in conducting similar non-pharmacological pain management research in routine care environments.

What administrative or coordination functions are expected of the Coordinating Center?

The Coordinating Center serves as the central administrative and coordination hub for PMC. It supports the PMC Steering Committee and its subcommittees by organizing meetings, maintaining documentation, facilitating cross-project communication, and supporting consistent processes for decision-making and collaborative work.

What is the purpose of having a single Coordinating Center?

The opportunity is designed to sustain a centralized coordinating infrastructure that keeps PMC functioning as a cohesive national program rather than a set of unrelated projects, while strengthening shared infrastructure and a common playbook for embedded pain management research across NIH, DoD, and VA contexts.

Who can apply?

Eligibility is broad across many U.S.-based organization types, including (as listed in the opportunity summary): state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses); and small businesses, among others.

Are specific institution categories highlighted as eligible?

Yes. The opportunity highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes faith-based or community-based organizations and U.S. territories or possessions.

Are foreign organizations eligible to apply?

No. The opportunity is restricted to domestic applicants. Non-U.S. entities (foreign organizations and foreign institutions) cannot apply.

Can a U.S. organization include a non-U.S. component in its application?

No. Non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed.

What agencies are involved in the collaboratory supported by this award?

The collaboratory is described as the NIH-DoD-VA Pain Management Collaboratory, reflecting involvement and collaboration across the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA).

What is the award ceiling?

The listed award ceiling is $1,300,000.

What is the application closing date shown in the provided information?

The original application closing date listed is August 31, 2023. The record is noted as created on June 28, 2023.

What type of funding opportunity is this described as?

It is described as a discretionary funding opportunity under a cooperative agreement mechanism, in the health and education activity category.

What CFDA numbers are associated with this opportunity?

The opportunity is associated with CFDA numbers 93.213, 93.273, and 93.361.

What is the overarching goal of supporting this Coordinating Center?

The goal is to sustain a centralized coordinating infrastructure that improves how pragmatic, health-system-partnered research on non-drug pain management is designed, implemented, and shared across NIH, DoD, and VA settings, ultimately supporting scalable improvements in pain care for service members, veterans, and their families.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

Previous opportunity: NT-23-01: Addressing Key Information Gaps in Acoustic Ecology of North Atlantic Right Whales

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AT 24 002

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AT 24 002) also looked into and applied for these:

Funding Opportunity
ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed) Apply for RFA OD 23 018

Funding Number: RFA OD 23 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Apply for PA 23 231

Funding Number: PA 23 231
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 037

Funding Number: RFA CA 23 037
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 036

Funding Number: RFA CA 23 036
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $325,000
NIH-DoD-VA Pain Management Collaboratory ? Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 24 004

Funding Number: RFA AT 24 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 25 014

Funding Number: RFA DA 25 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 23 246

Funding Number: PAR 23 246
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $475,000
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) Apply for RFA DA 25 020

Funding Number: RFA DA 25 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) Apply for RFA DA 25 019

Funding Number: RFA DA 25 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required) Apply for RFA DA 25 002

Funding Number: RFA DA 25 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional) Apply for RFA DA 25 001

Funding Number: RFA DA 25 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 23 254

Funding Number: PAR 23 254
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 23 255

Funding Number: PAR 23 255
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 23 245

Funding Number: PAR 23 245
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Apply for PAR 23 259

Funding Number: PAR 23 259
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 23 243

Funding Number: PAR 23 243
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 23 242

Funding Number: PAR 23 242
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Apply for PAR 23 264

Funding Number: PAR 23 264
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 273

Funding Number: PAR 23 273
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) Apply for PAR 23 244

Funding Number: PAR 23 244
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 24 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: